In 2022, the global intraoperative radiation therapy systems market is expected to be worth US$ 55.9 million. The application of therapeutic stages of radiation to the tumour site is known as IORT. IORT is frequently used in the multidisciplinary treatment of privately advanced and recurring disease, alongside outer beam radiation, chemotherapy, and surgery. Request Sample@ …
Category Archives: Healthcare Trends
Gastrointestinal Rare Diseases Treatment Market to expand at a 3.7% value CAGR by 2032
The global gastrointestinal rare diseases treatment market was worth US$ 1,314.8 million in 2022 and is expected to be worth US$ 1,965 million by 2032, growing at a CAGR of 3.7% during the forecast period. The increasing awareness of gastrointestinal diseases and the development of various medications can be attributed to the growth of the …
Diagnostic Exosome Biomarkers Market is expected to secure US$ 904.1 Million by 2032
In 2022, the global diagnostic exosome biomarkers market is expected to be worth US$ 172.1 million. From 2022 to 2032, the market is expected to grow at a CAGR of 16.3%, with a market value of US$ 904.1 million. The rising prevalence of cancer, ongoing research on exosomes, and the increasing number of clinical studies …
Dental Delivery System Market is expected to garner a value of US$ 918.1 million by 2032
The global dental delivery system market is expected to be worth US$ 561.0 million by the end of 2022, rising at a 4.6% CAGR to US$ 918.1 million by 2032. Dental delivery systems enable integration as well as the selection of mounting locations for any dental equipment required in an operator. The method of dentistry …
Infant Incubators Market is expected to reach US$ 518.2 Million by 2032, at a CAGR 4.7%
As per Future Market Insights, the global Infant Incubators Market was valued at around US$ 311.6 Million in 2021 and is projected to exhibit a CAGR of 4.7% over the forecast period. It is set to reach an estimated valuation of US$ 518.2 Million in 2032. The global infant incubators market is growing due to increased awareness regarding the health of newborns, rising …
Bone Regeneration Market is expected to reach US$ 7.4 Billion by 2032, at a CAGR 3.8%
According to Future Market Insights (FMI), the global bone regeneration market recorded a market value of US$ 7.4 Billion in 2032 and is further expected to grow at a CAGR of 3.8% over the forecast period (2022 to 2032). The sales in the market are expected to reach US$ 7.4 Billion by the end of 2032. A well-organized and complex physiological process of …
Biosensors Market is projected to witness a CAGR of 9.5% by the end of 2033 | FMI
According to Future Market Insights’ newly released Biosensors Market analysis report, the global market size of the Biosensors Market in 2022 will be US$ 24.5 Billion. The projected market growth is expected to be significantly higher than the historical growth, with a CAGR of 9.5% from 2023 to 2033. Medical biosensors are expected to be …
Continue reading “Biosensors Market is projected to witness a CAGR of 9.5% by the end of 2033 | FMI”
Covid-19 Vaccine Packaging and Delivery Devices Market is projected to reach a valuation of US$ 2.2 Billion by 2033 | FMI
According to Future Market Insights‘ newly released COVID-19 Vaccine Packaging and Delivery Devices Market analysis report, global sales of the Covid-19 Vaccine Packaging and Delivery Devices in 2022 were held at US$ 1.1 Billion. The market is expected to reach a valuation of US$ 2.2 billion by 2033, with a CAGR of 7.1% between 2023 …
Hyperammonemia Treatment Market is expected to reach US$ 2 Billion by 2033 | FMI Analyst
The Hyperammonemia Treatment Market is expected to be worth US$ 1,318.05 million in 2023, with a CAGR of 4.77% from 2023 to 2033. The market value of hyperammonemia treatment is expected to reach US$ 2 billion by the end of the decade. With the latest insights and statistics from the biggest pharmaceutical and healthcare device …
PCSK9 Inhibitors Market is expected to garner a market value of US$ 13 Billion by 2033 | FMI Analyst
The global PCSK9 Inhibitors Market had a market value of US$ 3 billion in 2023 and is expected to reach a market value of US$ 13 billion by 2023-2033, at a CAGR of 15.8%. Inhibitors of pro-protein convertase subtilisin Kexin type 9 (PCSK9) are drugs used to lower cholesterol levels. PCSK9 is a protein produced …